FORGOTTEN HISTORY: Clarivate - Caught on Camera

Clarivate Releases Journal Citation Reports 2026

LONDON, June 17, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the release of the Journal Citation Reports 2026. Now in its sixth decade, Journal Citation Reports (JCR) continues to provide a publisher-neutral framework for assessing journal influence across the global research…

AAP · Jun 17

Clarivate's IPfolio Selected by Mitsubishi Fuso

LONDON, June 15, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today that Mitsubishi Fuso Truck and Bus Corporation has selected IPfolio as its intellectual property (IP) management solution. IPfolio provides Mitsubishi Fuso with a modern, scalable foundation for IP management, bringing together…

AAP · Jun 15

Clarivate Introduces IPOne

LONDON, May 29, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced IPOne, a unified platform that combines purpose-built AI agents and trusted proprietary data to power intellectual property (IP) research and workflows across enterprise environments. IPOne is being developed in collaboration with…

AAP · May 29

Winbond Taps Clarivate's IPfolio To Supercharge Its Intellectual Property Operations

Clarivate Plc. (NYSE:CLVT) said it has helped Winbond Electronics Corporation modernize its intellectual property operations using IPfolio, a cloud-based management platform that streamlines data handling and boosts efficiency.

Benzinga · Oct 7, 2025

Appetite-regulating Hormones In Focus As First Nobel Prizes Fall

Research into hormones that regulate appetite is seen leading the race for the Nobel Prize in Medicine, to be awarded Monday -- the first in this year's Nobel season.

International Business Times · Oct 6, 2025

Bargains Galore? 3 Stocks With Insider Buying in the Millions

Clarivate, Prospect Capital, and Nine Energy Service insiders bought millions in stock. See what’s driving this insider confidence.

MarketBeat · Dec 10, 2024

Cancer, Cardiovascular Drugs Tipped For Nobel As Prize Week Opens

Cancer research or drugs treating cardiovascular illnesses could win a Nobel Prize on Monday when a week of laureate announcements kicks off, bringing a ray of optimism to a world beset by crises.

International Business Times · Oct 7, 2024

Exor Acquires 10% Stake In Clarivate, Potential Increase To 17.5%

Exor acquires a stake in Clarivate to leverage data-driven solutions for innovation and growth in the industry.

Top News · Mar 4, 2024

Pushing the boundaries to provide innovative, sustainable solutions

THE ARTICLES ON THESE PAGES ARE PRODUCED BY BUSINESS REPORTER, WHICH TAKES SOLE RESPONSIBILITY FOR THE CONTENTS

The Independent UK · Jun 28, 2023

What 4 Analyst Ratings Have To Say About Clarivate

Within the last quarter, Clarivate (NYSE:CLVT) has observed the following analyst ratings:

Benzinga · Jul 1, 2022